Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies
Cluster of differentiation 44 (CD44), a cell surface adhesion molecule overexpressed in cancer stem cells, has been implicated in chemoresistance. This scoping review, following PRISMA-ScR guidelines, systematically identified and evaluated clinical studies on the impact of CD44 expression on chemot...
Main Authors: | Zihao Wu, Jillian Lu, Andrew Loo, Nathan Ho, Danny Nguyen, Po Yueh Cheng, Ali I. Mohammed, Nicola Cirillo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/6/3141 |
Similar Items
-
The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
by: Nicola Cirillo
Published: (2023-10-01) -
CD44 in Bladder Cancer
by: Jason Duex, et al.
Published: (2024-03-01) -
GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer
by: Chen Chen, et al.
Published: (2022-07-01) -
CD44+/CD24- Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study
by: Unedo Hence Markus Sihombing, et al.
Published: (2022-10-01) -
Structural Constraint of Osteopontin Facilitates Efficient Binding to CD44
by: Gulimirerouzi Fnu, et al.
Published: (2021-05-01)